Shireen KhanSenior Director, Biologics at ChemPartner
Shireen S. Khan PhD is currently a Senior Director of Biologics at ChemPartner, located in South San Francisco, where she leads the Biologics group in expanding the antibody discovery capabilities through B cell cloning on the Beacon platform. She also leads multiple therapeutic antibody discovery programs for small, mid-sized and large biotech and pharmaceutical companies. Prior to joining ChemPartner, Shireen led the in vitro cell and functional biology group at XOMA and advanced several therapeutic antibody candidates through in vitro and in vivo proof of concept studies. She completed her PhD in Biology at the University of California, San Diego and Post-doctoral training at DNAX Research Institute in Palo Alto, CA where she studied cancer cell biology and cell cycle checkpoints.